Search results for: 'postur point analyst for laboratory develop'

23 Jun 2016  |  North America  |  Market Research

Growth Opportunities in the US Point-of-care Testing Market

Digital Health Meets Point of Care—Emergence of Mobile Molecular Diagnostics

Infographics

×

The US point-of-care testing (POCT) study provides an extensive analysis for 13 segments: hematology, urinalysis, infectious disease, cardiac, HbA1c, glucose, fecal occult blood test/fecal immunochemical test (FOBT/FIT), coagulation PT/INR, coagulation APTT/ACT, cholesterol, pregnancy, drugs of abuse, and blood gas and electrolytes. Key trends and ...

Electronic devices are an integral part of human life, serving a multitude of functionalities. Many application areas for example, electronic gadgets, health monitoring and medical devices, activity tracking, smart cards, and wearable electronics require lightweight, flexible, and compact energy storage solutions. The focus on miniaturization and c...

This research study provides a comprehensive assessment of the recent trends, technological advancements, and strategic developments shaping the global laboratory automation industry. The analysis traces the evolution of laboratory automation from task-specific automation systems to integrated, intelligent laboratory ecosystems enabled by robotics,...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...

Developed Asia-Pacific economies, such as Japan, South Korea, Taiwan, Australia, and Singapore, are at the forefront of advanced technology and industrial innovation. These countries have strong ambitions to sustain global tech leadership. However, they face strategic pressures from shifting geopolitics, energy-security challenges, and efforts to r...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

The laboratory analytical instruments market is segmented into two broad markets of chromatographs and spectrophotometers. Each segment discusses applicable end-user applications, product type breakdown. Each segment also discusses current issues facing the market, revenue forecasts, market and technology trends, and competitive analysis. Challenge...

Laboratory personnel were invited to participate in an online survey in June 2014. A total of 366 laboratory decision makers qualified to complete the survey, answering questions about their use of laboratory information management systems (LIMS). Respondents organization types include academic laboratory or core facility; federal, state, or local...

This research service analyzes the market for clinical laboratory analyzers within the United States. The United States market was divided into the clinical chemistry, immunoassay, integrated, hematology, hemostasis, and blood gas analyzer market segments. Each segment of this service covers market drivers, market restraints, competitive structur...